NEW YORK, September 29, 2016 /PRNewswire/ --
The debate to legalize marijuana or not has been an on-going topic for many decades. There have been numerous scientific studies of the chemicals in marijuana, which has led to as few as only two U.S. Food and Drug Administration approved medications (dronabinol and nabilone) containing cannabinoids. Due to the marijuana plant containing essential chemicals that may help relief illnesses or symptoms, many people have fought to legalize marijuana for medical intentions. MassRoots Inc. (OTCQB: MSRT), Cara Therapeutics Inc. (NASDAQ: CARA), Terra Tech Corp. (OTCQXS: TRTC), General Cannabis Corporation (OTCQB: CANN), Growblox Sciences Inc. (OTCQB: GBLX).
By 2020, ArcView Market Research has projected that medical and recreational use of cannabis in the market is likely to reach over $23 billion. Searching the possibilities of legal marijuana products might be considered difficult because there's no standard for evaluating the quality or specific type of cannabis product.
One of the largest technology platforms for the cannabis industry, MassRoots Inc. (OTCQB: MSRT) aims to lead the demand-side of the government controlled cannabis markets by providing information shared by enthusiasts on its iOS App and Google Play mobile network platform. This will allow cannabis customers to seek for specific products and dispensaries. The company currently has over 900,000 users with an active community that engages over 300,000 times daily on its network generating a substantial growth rate of 30,000 new monthly users.
MassRoots Inc. (MSRT) generates most of its earnings through sales advertisements, with Uber and Univision being a few of its paying advertisers. The company has plans to complete a monthly premium subscription for its users in order to associate them with their finest offers, as well as industry data. By accessing data from many cannabis consumers, MassRoots is able to gain knowledge of consumer trends very few industries have.
Recently, MassRoots Inc. (MSRT) announced their second quarter financial results that has generated more revenue this quarter than all previous quarters combined. Partnered with sizeable reductions in operating expenditures made this summer, the company expects to be cash-flow positive on a monthly basis by the end of 2016. Over 75% of sales are expected to come solely from the Colorado and California markets, while the November 2016 elections have the potential to open or expand markets in 8 additional states. MassRoot's two closest comparables, Weedmaps and Leafly, are expected to generate more than $25 million and $15 million, respectively, in digital advertising revenue during 2016. Already with comparable user-bases to both of these services, the company's annual revenue run rate expects will grow to this range within the next 12 to 18 months.
Clinical-stage biopharmaceutical company, Cara Therapeutics Inc. (NASDAQ: CARA), has studied that the effects of cannabis has led to an endogenous system of ligands in humans involved in a number of physiological processes including pain and inflammation. Cara owns CR701, an incidental acting cannabinoid receptor antagonist pain drug and CR845, Cara's leading pain medication.
Vertically integrated cannabis-focused agriculture company, Terra Tech Corp. (OTCQX: TRTC) has recently announced that its subsidiary company, Edible Garden, a retail seller of fresh hydroponic produce, herbs, and floral products, has started shipping its line of 4 inch potted living herbs to private American reginal supermarket chain, Wegmans Food Markets Inc.
Terra Tech integrates the natural world with technology to create sustainable solutions for medical cannabis production, extraction and distribution, plant science research and development, food production and Closed Environment Agriculture. Through this development, the company has created relevant brands in both the cannabis and agriculture industries.
General Cannabis Corporation (OTCQB: CANN) has recently completed the initial closing of a $3 million private placement transaction with numerous private parties with current noteholders. General Cannabis offers various products and services to companies in the cannabis industry. Their integrated solution ranges from operational and compliance consulting to security and marketing to financing needs. These segments include Security and Cash Management Services; Marketing and Products; Consulting and Advisory, and Finance and Real Estate.
Growblox Sciences Inc. (OTCQB: GBLX) through its subsidiaries, centers on research and development of medical-grade cannabis medication and treatment. Growblox produces medical-grade cannabis, cannabis concentrates, and cannabinoid treatments using diversified technologies in plant biology, cultivation, and distillation techniques joined with biotechnology. The company is currently in development of controlled-climate indoor agricultural technology growing and cultivation suites, including TissueBLOX, GrowBLOX, CureBLOX, and ExtractionLAB.
Subscribe Now! Watch us report from NYSE https://www.youtube.com/FinancialBuzzMedia
Follow and talk to us on Instagram: https://www.instagram.com/financialbuzz
Facebook Like Us to receive live feeds: https://www.facebook.com/Financialbuzz/
FinancialBuzz.com, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, FinancialBuzz.com creates 100% unique original content. FinancialBuzz.com also provides financial news PR branding, marketing and advertising for third parties for disseminating news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.
For further information:
Media Contact: Danny A, firstname.lastname@example.org, +1-877-601-1879